ライフサイエンスコーパス: central nervous system tumor

1 is the most common and deadly of the primary central nervous system tumors.

2 ommon tumors, representing 15% to 25% of all central nervous system tumors.

3 n, accounting for approximately one-fifth of central nervous system tumors.

4 antitumor benefit in patients with malignant central nervous system tumors.

5 -causing genetic changes in the evolution of central nervous system tumors.

6 e (TSG) for malignant rhabdoid and childhood central nervous system tumors.

7 inately inhibiting prosurvival mechanisms in central nervous system tumors.

8 tute to evaluate the incidence of MSI in 206 central nervous system tumors.

9 strocytoma is one of the most deadly primary central nervous system tumors.

10 well as in human gynecological, breast, and central nervous system tumors.

11 expression and acquired genetic mutations in central nervous system tumors.

12 r on the biology and management of pediatric central nervous system tumors.

13 ocalized pruritus is a rare manifestation of central nervous system tumors.

14 Gliomas represent approximately 30% of all central nervous system tumors and 80% of malignant brain

15 eningiomas constitute the second most common central nervous system tumor, and yet relatively little

16 We demonstrate that VHL disease-associated central nervous system tumors are composed of developmen

17 Primary central nervous system tumors are the second most common

18 As treatment with chemotherapy for central nervous system tumors becomes more successful, n

19 sequelae among patients without significant central nervous system tumor burden and to describe the

20 d not only in familial schwannomas and other central nervous system tumors, but also in malignant tum

21 In both breast cancers and central nervous system tumors, cancer cells differ in th

22 Central nervous system tumors carry grave clinical progn

23 The methionine-dependent central nervous system tumor cell lines DAOY (medullobla

24 uct of the TSC2 gene, seen in both renal and central nervous system tumors from TSC patients?

25 However, little is known about how central nervous system tumors guard against immune eradi

26 nasmuch as induction of humoral responses by central nervous system tumors has been reported to be mi

27 Meningiomas are common central nervous system tumors; however, the mechanisms u

28 Meningiomas are common central nervous system tumors; however, the molecular me

29 tent immune responses against peripheral and central nervous system tumors; however, variable results

30 sociated cancer is medulloblastoma, a common central nervous system tumor in children.

31 tiforme (GBM), the most common and malignant central nervous system tumor in humans, is highly prolif

32 One-third of all primary central nervous system tumors in adults are meningiomas.

33 nesis of meningiomas, one of the most common central nervous system tumors in humans.

34 We report that 14% of ptc+/- mice develop central nervous system tumors in the posterior fossa by

35 Refined and novel approaches to modeling central nervous system tumors, including gliomas, mening

36 e inactivation results in the development of central nervous system tumors, including schwannomas, me

37 readily detected in normal brain, malignant central nervous system tumors, including tumors metastat

38 Glioblastoma is the most common central nervous system tumor, is associated with high mo

39 cancer cell growth, especially against human central nervous system tumor lines such as SF-295 cells.

40 Compared to astrocytomas, the most common central nervous system tumor, little is known about the

41 Although meningiomas are common central nervous system tumors, little is known about the

42 lterations in gene expression found in human central nervous system tumors may actually contribute to

43 Malignant glioma is the most common central nervous system tumor of adults and is associated

44 n detected not only in schwannomas and other central nervous system tumors of NF2 patients but also i

45 maternal age increased risk of leukemia and central nervous system tumors, older paternal age was no

46 e tumors (OR, 2.1; 95% CI, 1.8-2.5; P<.001), central nervous system tumors (OR, 1.7; 95% CI, 1.5-2.0;

47 of leukemia, neuroblastoma, retinoblastoma, central nervous system tumors, or renal or germ-cell tum

48 With the exception of primary central nervous system tumors, organ recovery is no long

49 Childhood primary central nervous system tumors remain a therapeutic conun

50 S was not associated with the peripheral and central nervous system tumors seen in NF1.

51 ia (P-388), human melanoma (RPMI), and human central nervous system tumor (TE671) cells.

52 Brainstem gliomas (BSG) are a rare group of central nervous system tumors that arise mostly in child

53 Meningiomas are central nervous system tumors that originate from the me

54 Analysis of a central nervous system tumor tissue microarray revealed

55 7020 is an effective antitumor agent for non-central nervous system tumor xenografts with an excellen